Echo-Doppler mitral flow monitoring: An operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure

Journal of the American College of Cardiology

Volumn 38, Issue 6, 2001, Pages 1675-1684

  Capomolla, Soccorso ^a,b   Pinna, GianDomenico ^a   Febo, Oreste ^a   Caporotondi, Angelo ^a   Guazzotti, Giampaolo ^a   La Rovere, Maria Teresa ^a   Gnemmi, Marco ^a   Mortara, Andrea ^a   Maestri, Roberto ^a   Cobelli, Franco ^a  

^a IRCCS   (Italy)

^b Montescano Medical Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG MONITORING; DRUG TOLERABILITY; DRUG TOLERANCE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; CARBAZOLES; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MIDDLE AGED; MITRAL VALVE; NITROPRUSSIDE; PREDICTIVE VALUE OF TESTS; PROPANOLAMINES; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0035890320     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01609-6     Document Type: Article

References (37)

1. Changing the remodelling process in heart failure: Basic mechanisms and laboratory results
2. Molecular and cellular mechanisms of myocardial failure
3. Regulation of hypertrophy and atrophy in cultured adult heart cells
4. Persistent stimulation of beta-adrenergic signaling triggers degeneration and apoptosis of cardiac myocytes
5. Neurohormonal activation in preclinical heart failure: Remodeling and the potential for intervention
6. Structural basis for heart failure: Ventricular remodeling and its pharmacological inhibition
7. Extracellular matrix remodeling in heart failure: A role of de novo angiotensin II generation
8. Risk stratification in chronic heart failure
9. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiographic and hemodynamic correlation and prognostic implications
10. Prognostic value of Doppler transmitral flow pattern in patients with congestive heart failure
11. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure
12. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure
13. Left ventricular filling in dilated cardiomyopathy: Relation to functional class and hemodynamics
14. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling
15. Clinical effects of β-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials
16. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure: Improvements in hemodynamic, contractile and diastolic performance with bucindolol
17. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
18. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
19. Ventricular remodelling: Consequences and therapy
20. Altered myocardial force-frequency relation in human heart failure
21. Left ventricle
22. Reproducibility of left ventricular volumes by two-dimensional echocardiography
23. A new method for quantification of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice
24. Relation of transmitral flow patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study
25. β-blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol
26. A note on a general definition of the coefficient of determination
27. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
28. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure
29. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
30. Double-bind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure
31. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
32. Echocardiographic Doppler evaluation of left ventricular diastolic function: Physics and physiology
33. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography
34. Left ventricular diastolic function: Comparison of pulsed Doppler echocardiographic and hemodynamic indexes in subjects with and without coronary artery disease
35. Diastolic dysfunction in heart failure
36. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: Hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function and ventricular function
37. Importance of hemodynamic response to therapy in predicting survival in patients with ejection fraction <20% secondary to ischemic or nonischemic dilated cardiomyopathy